• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症(硬皮病)和原发性雷诺现象患者皮肤中细胞内及细胞外相关转化生长因子β的免疫组织化学定位

Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon.

作者信息

Gabrielli A, Di Loreto C, Taborro R, Candela M, Sambo P, Nitti C, Danieli M G, DeLustro F, Dasch J R, Danieli G

机构信息

Istituto di Clinica Medica, Università di Ancona, Italy.

出版信息

Clin Immunol Immunopathol. 1993 Sep;68(3):340-9. doi: 10.1006/clin.1993.1136.

DOI:10.1006/clin.1993.1136
PMID:8370185
Abstract

We have investigated the distribution of TGF beta using antibodies specific for its intracellular and extracellular forms in full-thickness biopsies of patients with SSc, primary Raynaud's phenomenon (PRP), systemic lupus erythematosus (SLE), and from normal subjects. Nine of 11 SSc biopsies demonstrated intracellular TGF beta in endothelial cells while only 6 exhibited extracellular TGF beta. Endothelial cells in skin biopsies of all PRP patients displayed both intracellular and extracellular TGF beta. All other control biopsies were negative. In patients with PRP, some positively staining fibroblasts were found scattered throughout the dermis. Lastly, extracellular TGF beta was localized in the papillary dermis of PRP and SSc biopsies and in all the dermal layers of SLE patients. No significant staining of TGF beta was observed in the endothelial cells, fibroblasts, or in the extracellular matrix of the majority of biopsies from normal subjects. These data suggest that TGF beta may be one of the cytokines involved in the early stages of pathogenesis of SSc, and that endothelial cells in SSc and PRP may be a source and/or a target of TGF beta.

摘要

我们使用针对转化生长因子β(TGFβ)细胞内和细胞外形式的特异性抗体,对系统性硬化症(SSc)、原发性雷诺现象(PRP)、系统性红斑狼疮(SLE)患者以及正常受试者的全层活检组织进行了TGFβ分布情况的研究。11例SSc活检组织中有9例在内皮细胞中显示出细胞内TGFβ,而只有6例显示出细胞外TGFβ。所有PRP患者皮肤活检中的内皮细胞均同时显示出细胞内和细胞外TGFβ。所有其他对照活检均为阴性。在PRP患者中,发现一些阳性染色的成纤维细胞散在于整个真皮层。最后,细胞外TGFβ定位于PRP和SSc活检组织的乳头真皮层以及SLE患者的所有真皮层。在大多数正常受试者的活检组织中,未在内皮细胞、成纤维细胞或细胞外基质中观察到TGFβ的显著染色。这些数据表明,TGFβ可能是参与SSc发病早期阶段的细胞因子之一,并且SSc和PRP中的内皮细胞可能是TGFβ的来源和/或靶点。

相似文献

1
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon.系统性硬化症(硬皮病)和原发性雷诺现象患者皮肤中细胞内及细胞外相关转化生长因子β的免疫组织化学定位
Clin Immunol Immunopathol. 1993 Sep;68(3):340-9. doi: 10.1006/clin.1993.1136.
2
Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon.转化生长因子β1的免疫细胞化学定位及血清学检测。与弥漫性和局限性系统性硬化症、硬斑病及雷诺现象中I型前胶原和炎症细胞标志物的关联。
Arthritis Rheum. 1994 Feb;37(2):278-88. doi: 10.1002/art.1780370218.
3
Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis.系统性硬化症患者唇腺中肥大细胞、细胞外基质成分、转化生长因子β亚型及转化生长因子β受体的表达
Ann Rheum Dis. 2000 Mar;59(3):183-9. doi: 10.1136/ard.59.3.183.
4
Vascular damage and lack of angiogenesis in systemic sclerosis skin.系统性硬化症皮肤中的血管损伤与血管生成不足。
Clin Rheumatol. 2003 Sep;22(3):196-202. doi: 10.1007/s10067-003-0698-1.
5
Immunohistological demonstration of transforming growth factor-beta isoforms in the skin of patients with systemic sclerosis.系统性硬化症患者皮肤中转化生长因子-β亚型的免疫组织学证明
Clin Immunol Immunopathol. 1993 Nov;69(2):199-204. doi: 10.1006/clin.1993.1170.
6
Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta.系统性硬化症和正常皮肤成纤维细胞对转化生长因子-β的反应中纤连蛋白的释放
J Rheumatol. 1991 Feb;18(2):241-6.
7
Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts.在硬皮病成纤维细胞中,转化生长因子β对血小板衍生生长因子α受体的选择性上调作用。
J Exp Med. 1992 May 1;175(5):1227-34. doi: 10.1084/jem.175.5.1227.
8
Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.硬皮病角质形成细胞可促进成纤维细胞活化,且不依赖于转化生长因子β 。
Rheumatology (Oxford). 2017 Nov 1;56(11):1970-1981. doi: 10.1093/rheumatology/kex280.
9
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.丛状蛋白-D1/信号素3E通路可能导致系统性硬化症中血管张力控制失调和血管生成缺陷。
Arthritis Res Ther. 2015 Aug 21;17(1):221. doi: 10.1186/s13075-015-0749-4.
10
Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis.原发性雷诺现象和系统性硬化症中甲襞毛细血管尺寸增加。
Br J Rheumatol. 1996 Nov;35(11):1127-31. doi: 10.1093/rheumatology/35.11.1127.

引用本文的文献

1
Elucidating the cellular mechanism for E2-induced dermal fibrosis.阐明 E2 诱导的皮肤纤维化的细胞机制。
Arthritis Res Ther. 2021 Feb 27;23(1):68. doi: 10.1186/s13075-021-02441-x.
2
MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma.局限性硬皮病和弥漫性硬皮病中的 microRNA 表达异常。
J Clin Immunol. 2012 Jun;32(3):514-22. doi: 10.1007/s10875-011-9647-y. Epub 2012 Feb 4.
3
Pharmacotherapy of systemic sclerosis.系统性硬皮病的药物治疗。
Expert Opin Pharmacother. 2010 Apr;11(5):789-806. doi: 10.1517/14656561003592177.
4
A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity.TGFbeta 反应基因特征与弥漫性硬皮病的一个亚组相关,该亚组疾病严重程度增加。
J Invest Dermatol. 2010 Mar;130(3):694-705. doi: 10.1038/jid.2009.318. Epub 2009 Oct 8.
5
Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension.通过转化生长因子-β1/ Smad激活的内皮向间充质转化与特发性门静脉高压症的门静脉狭窄相关。
Am J Pathol. 2009 Aug;175(2):616-26. doi: 10.2353/ajpath.2009.081061. Epub 2009 Jul 16.
6
T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities.T细胞和B细胞在系统性硬化症发病机制中的作用:最新见解与治疗机遇
Curr Rheumatol Rep. 2006 Apr;8(2):123-30. doi: 10.1007/s11926-006-0052-0.
7
Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice.肥大细胞糜蛋白酶抑制剂对紧皮小鼠硬皮病发展的影响。
Br J Pharmacol. 2005 Jun;145(4):424-31. doi: 10.1038/sj.bjp.0706209.
8
Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis.系统性硬化症患者转化生长因子β1基因多态性分析
Ann Rheum Dis. 2002 Aug;61(8):678-81. doi: 10.1136/ard.61.8.678.
9
Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.系统性硬化症患者趋化因子(单核细胞趋化蛋白-1(MCP-1)、巨噬细胞炎性蛋白-1α(MIP-1α)和MIP-1β)产生增加:MCP-1和MIP-1α可能参与肺纤维化的发生发展。
Clin Exp Immunol. 1999 Jul;117(1):159-65. doi: 10.1046/j.1365-2249.1999.00929.x.
10
Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein.成纤维细胞前胶原生成的调节。转化生长因子-β1通过一种对百日咳毒素敏感的G蛋白诱导前列腺素E2生成,但不诱导前胶原合成。
Biochem J. 1995 Apr 1;307 ( Pt 1)(Pt 1):63-8. doi: 10.1042/bj3070063.